Quantitative analysis of receptor allosterism and its implication for drug discovery
Authors:
- Rumin ZhangRZRumin Zhang
- Michael KavanaMKMichael Kavana
- 30 April 2015
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 10 (7) , 763-780
Abstract
G protein-coupled receptors represent the largest class of druggable targets and are known to be modulated by both orthosteric agonists and positive/negative allosteric modulators (PAMs/NAMs). Proper experimental design and data analysis for the dose matrix between an agonist and PAM or NAM are critical to elucidate the key parameters for understanding molecular mechanism and structure-activity relationship (SAR) in drug discovery. The authors provide an overview and best practice recommendations on the quantitative analysis of receptor allosterism. The authors propose a simple classification system for receptor modulators on the basis of their efficacy and affinity modifiers. The authors also outline the optimal assay designs for both fixed dose screening and dose matrix study of receptor modulators. The authors recommend the global curve fitting approach to reliably yield system- and modulator-specific parameters for SAR ranking. Furthermore, the authors suggest that the uncertainty in maximal system response has insignificant impact on SAR ranking. The authors anticipate that systems pharmacology models integrating both binding kinetics and functional allosterism will be needed to address the inherent limitations of current allosterism models.Keywords
This publication has 67 references indexed in Scilit:
- Role of β-arrestins and arrestin domain-containing proteins in G protein-coupled receptor traffickingCurrent Opinion in Cell Biology, 2014
- The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsinCurrent Opinion in Cell Biology, 2014
- G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological PerspectivesPharmacological Reviews, 2014
- Defining and characterizing drug/compound functionBiochemical Pharmacology, 2014
- Bridging the gap: bitopic ligands of G-protein-coupled receptorsTrends in Pharmacological Sciences, 2013
- Molecular Alliance—From Orthosteric and Allosteric Ligands to Dualsteric/Bitopic Agonists at G Protein Coupled ReceptorsAngewandte Chemie International Edition, 2012
- The Best of Both Worlds? Bitopic Orthosteric/Allosteric Ligands of G Protein–Coupled ReceptorsAnnual Review of Pharmacology and Toxicology, 2012
- Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouseGenomics, 2006
- Constitutive Activity and Inverse Agonists of G Protein-Coupled Receptors: a Current PerspectiveMolecular Pharmacology, 2003
- Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.Proceedings of the National Academy of Sciences, 1989